Shaping the future of personalized medicine is not all about developing expensive new drugs -- it will also mean revisiting older, cheaper medicines armed with new genetic knowledge.
Recent discoveries of genetic clues as to why medicines work better in some patients than others suggests combining new tests with old drugs will be a cost-effective approach -- attractive to governments and insurance companies, experts say.
Monday, October 12, 2009
Going back to the future in personalized medicine
Reuters reports:
